These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 157621)

  • 1. [The fine structure of treated Graves' disease. Morphological alterations after preoperative therapy with iodide, thionamides and lithium (author's transl)].
    Dralle H; Böcker W; Koch G
    Virchows Arch A Pathol Anat Histol; 1979 Jul; 383(2):181-93. PubMed ID: 157621
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves' disease.
    Shi GM; Xu Q; Zhu CY; Yang YL
    J Int Med Res; 2009; 37(2):576-82. PubMed ID: 19383254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electron microscopic and morphometric study of the cellular composition of several forms of goiter in man].
    Dmitrieva NP
    Tsitologiia; 1977 Oct; 19(10):1124-9. PubMed ID: 579702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in antithyroid drug treatment of Graves' disease.
    Okosieme OE; Lazarus JH
    Expert Opin Pharmacother; 2016 Oct; 17(15):2005-17. PubMed ID: 27615550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-pathological and histo-pathological studies on Graves' disease: with special reference to the correlation of morphological features and their clinical course (author's transl)].
    Ooi T
    Nihon Ika Daigaku Zasshi; 1981 Feb; 48(1):38-48. PubMed ID: 6895519
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
    Kallner G; Vitols S; Ljunggren JG
    J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peroxidase activity of thyroid tissue in toxic diffuse goiter. Difference among thyroids administered antithyroid drugs and potassium iodide].
    Hiyama Y; Hosoya T; Tarutani O; Ito K
    Nihon Naibunpi Gakkai Zasshi; 1986 Jan; 62(1):1-8. PubMed ID: 3754518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An enzyme histochemistry and electron microscopic study of chronic thyroiditis and Graves' disease (author's transl)].
    Mizukami Y; Matsubara F
    Nihon Naibunpi Gakkai Zasshi; 1980 Mar; 56(3):241-50. PubMed ID: 6154604
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of thyroid volume on the effect of methimazole in Japanese subjects with mild Graves' disease.
    Kimura T; Matsuki M; Kaneto H; Mune T; Kaku K
    Eur J Intern Med; 2016 Dec; 36():e31-e32. PubMed ID: 27601286
    [No Abstract]   [Full Text] [Related]  

  • 10. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M; Larsen PR
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid protease activity in thyroid gland from patients with Graves' disease.
    Yoshinari M; Inoue K; Nakashima T; Okamura K; Shiroozu A; Nishitani H; Omae T; Torisu M; Noguchi S
    Metabolism; 1983 Apr; 32(4):348-54. PubMed ID: 6353140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of Graves' disease. Long term results (author's transl)].
    Boulard C; Louvet JP; Daumas S; Vallee I; Lapebie P
    Ann Endocrinol (Paris); 1980; 41(6):585-9. PubMed ID: 6894678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical studies of secretory and other granules associated with the endoplasmic reticulum in rat thyroid epithelial cells.
    Novikoff AB; Novikoff PM; Ma M; Shin WY; Quintana N
    Adv Cytopharmacol; 1974; 2():349-68. PubMed ID: 4140681
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitosis in rat thyroid epithelial cells in vivo. I. Ultrastructural changes in cytoplasmic organelles during the mitotic cycle.
    Zeligs JD; Wollman SH
    J Ultrastruct Res; 1979 Jan; 66(1):53-77. PubMed ID: 423323
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid gland in Graves' disease: victim or culprit?
    Chopra IJ; Solomon DH; Johnson DE; Chopra U
    Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo and in vitro evidence for iodide regulation of major histocompatibility complex class I and class II expression in Graves' disease.
    Schuppert F; Taniguchi S; Schröder S; Dralle H; von zur Mühlen A; Kohn LD
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3622-8. PubMed ID: 8855812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which anti-thyroid drug?
    Cooper DS
    Am J Med; 1986 Jun; 80(6):1165-8. PubMed ID: 3755286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.